Search
Acalabrutinib is used in the treatment of chronic lymphocytic leukemia. Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).
Items | Specification |
Appearance | White to cream yellow powder |
Assay | ≥98% |
Molecular Formula | C26H23N7O2 |
Molecular Weight | 465.50652 |
Product parameters | |
Cas number: | 1420477-60-6 |
Appearance: | White to cream yellow powder |
Purity: | 98%min |
Package details: | 10mg/vial,1g/foil bag |
Brand: | Fortunachem |
Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: